FAIRFAX, Va. -- Local health departments in Northern Virginia, the District of Columbia, and Maryland are investigating an outbreak of serious skin reactions among at least 16 women who have developed the condition after receiving cosmetic injections in October and November 2004.
According to health officials, the women received the injections from a man who identified himself as a doctor from Colombia. He performed the procedures in private homes. The man was not licensed to practice medicine in Virginia, Maryland or the District of Columbia, and it is not known what substance was injected.
Suzanne Jenkins, VMD, MPH, acting state epidemiologist for the Virginia Department of Health, states, We dont know the scope of the problem at this point, but we are hoping to hear from people who have had these types of treatments in non-healthcare settings. Information will be regarded as strictly confidential and callers will help us to help others who have had problems healing after these injections.
The patients, ranging in age from late teens to 60s, have developed numerous signs and symptoms at the injection sites, including pain, redness, swelling, blisters and abscesses. Some complained of itching and increased skin sensitivity. Most patients began noticing problems about 6-10 weeks after their injections. There have been no deaths and no patients have required hospitalization.
At this time the cause of the reactions is not known, but it is being actively investigated by state and local health departments, the Division of Consolidated Laboratory Services, the Centers for Disease Control and Prevention (CDC), and medical providers across the region. Health departments have alerted medical providers to be aware of the situation and to contact local health departments should they see patients presenting with these symptoms.
Health officials strongly recommend against receiving injections of any substance from unlicensed providers. Anyone who has received an injection from an unlicensed medical provider outside a clinic or a hospital, for example a private home, should contact the Virginia Department of Health Regional Office at (703) 934-0627. All caller information will be kept strictly confidential. Officials hope to hear from people who have had reactions to these injections as well as from those who have not, so that they can quickly determine risk factors for reactions, identify the substance involved and provide specific treatment recommendations.
Source: Virginia Department of Health
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.
Reducing Hidden Risks: Why Sharps Injuries Still Go Unreported
July 18th 2025Despite being a well-known occupational hazard, sharps injuries continue to occur in health care facilities and are often underreported, underestimated, and inadequately addressed. A recent interview with sharps safety advocate Amanda Heitman, BSN, RN, CNOR, a perioperative educational consultant, reveals why change is overdue and what new tools and guidance can help.
New Study Explores Oral Vancomycin to Prevent C difficile Recurrence, But Questions Remain
July 17th 2025A new clinical trial explores the use of low-dose oral vancomycin to prevent Clostridioides difficile recurrence in high-risk patients taking antibiotics. While the data suggest a possible benefit, the findings stop short of statistical significance and raise red flags about vancomycin-resistant Enterococcus (VRE), underscoring the delicate balance between prevention and antimicrobial stewardship.
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
CDC Urges Vigilance: New Recommendations for Monitoring and Testing H5N1 Exposures
July 11th 2025With avian influenza A(H5N1) infections surfacing in both animals and humans, the CDC has issued updated guidance calling for aggressive monitoring and targeted testing to contain the virus and protect public health.
A Helping Hand: Innovative Approaches to Expanding Hand Hygiene Programs in Acute Care Settings
July 9th 2025Who knew candy, UV lights, and a college kid in scrubs could double hand hygiene adherence? A Pennsylvania hospital’s creative shake-up of its infection prevention program shows that sometimes it takes more than soap to get hands clean—and keep them that way.